Parnell Pharmaceuticals Holdings Ltd. (PARNF)

[Wildbilly]

PARN: 06/18/2016 New Efficacy Data for Zydax(R)

and Product Pipeline Updates

Parnell Pharmaceuticals Holdings Ltd to Host Inaugural Investor Day on June 18, 2015 - MarketWatch

Parnell Pharmaceuticals Holdings Ltd PARN, +4.92% a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that the company will hold its first Investor Day event for the institutional investment and research analyst community on Thursday, June 18th, 2015 in New York City. Registration begins at 8 am and the formal presentation and webcast will began at 8:30 am Eastern time.

Management will present results from the Pivotal Efficacy Clinical Study of Zydax®, Parnell's disease-modifying osteoarthritis therapy for dogs and horses, as well as global commercialization plans for Zydax and Glyde®, Parnell's nutraceutical product for osteoarthritis management. The program will feature in-depth presentations by Parnell's executive team on development progress in Parnell's new product pipeline, and noted industry experts will provide insights into new and emerging markets in the animal healthcare industry.

The event will be hosted by Chief Executive Officer Robert Joseph and Chief Scientific Officer Edward Robb, DVM, MS, DAC, VN, as well as featured expert speakers:

Chris Ragland, Chief Executive Officer, Animaltyix: The largest provider of syndicated market data will present an overview of the market size of various animal health industries
Professor Duncan Lascelles, BSc, BVSc, PhD, CertVA, DSAS(ST), DECVS, DACVS, North Carolina State University, College of Veterinary Medicine, and preeminent Key Opinion Leader on pain and mobility in dogs
Qualified institutional investors and research analysts may register to attend the Parnell 2015 Investor Day by contacting Karen Bergman or Susan Pietropaolo, BCC Partners at [e-mail] or [e-mail].

Parnell invites the public to listen to the presentations via a live webcast that will be accessible under the Investor Relations section of the company's website, http://investors.parnell.com/events.cfm. Parnell will maintain an archived replay of the webcast on its website for 30 days after the conference.

http://www.marketwatch.com/story/parnell-pharmaceuticals-holdings-ltd-to-host-inaugural-investor-day-on-june-18-2015-2015-06-01-81843026

.